Latest Breaking News On - Multi drug resistant - Page 1 : comparemela.com

TB Eradication

Despite the advancements in tuberculosis (TB) surveillance and genomic sequencing technologies, the disease continues to be a global health crisis, constituting an excess of 10.6 million people contracting the bacterial infection in 2022.

South africaBelinda ngongoGlobal health external affairsWorld health organisationNext generation sequencingNext generationMulti drug resistant

Zimbabwe: Portable X-Ray Machines, Ai Take TB Diagnosis to Remote Areas

Zimbabwe: Portable X-Ray Machines, Ai Take TB Diagnosis to Remote Areas
allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.

Fungai kavengaLucica ditiuMt everestKala pattarRumbidzayi zinyukeTb partnershipMinistry of healthGuinness world recordArtificial intelligenceMulti drug resistantChild care dr fungai kavenga

Antimicrobial resistance causing 300,000 deaths annually in Pakistan

AMR is the third leading cause of death in the country, say experts

Afreenish amirJaved akramShahzad ali khanZulfiqar bhuttaWajiha javedGetz pharmaPunjab healthPublic health at getz pharmaHealth services academyPakistan society of internal medicineVice chancellorAntimicrobial resistancePunjab health ministerPakistan societyInternal medicineProfessor javed akram

Forum: HIV Plus TB Equals Epidemic Disaster In Africa

Forum: HIV Plus TB Equals Epidemic Disaster In Africa
science20.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science20.com Daily Mail and Mail on Sunday newspapers.

New south walesUniversity of cape townWestern capeSouth africaTugela ferryKwazulu natalCape townRichard chaissonVeronica millerBacille calmette guDiane havlirUs centers for diseaseInternational aids societyForum for collaborativeMelinda gates foundationConsortium to respond

Recce Pharmaceuticals Provides Business Update

Promising Minimum Inhibitory Concentration (MIC) activity in Phase I/II trial for urinary tract infections (UTI) and urosepsis with an increase in dosage expected to begin in the next several weeksExpansion of Phase I/II trial for diabetic foot infections (DFI) with efficacy achieved and now moving towards the initiation of a Phase III registrational trial in Indonesia scheduled to commence in Q3 2024RECCE® 327 (R327) shown to be effective against more than 300 strains of bacterial pathogens dur

United statesNew south walesJames grahamAndrew geddesJohn prendergastAlanw duntonMichael fitzhughHannah tsunemotoMichele diliziaUs department of defenseInternational conventionAmerican society for clinical pharmacologyDrug administrationDevelopment authorityRecce pharmaceuticals ltdBiomedical advanced research